709 related articles for article (PubMed ID: 19226374)
1. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
[TBL] [Abstract][Full Text] [Related]
2. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
[TBL] [Abstract][Full Text] [Related]
3. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.
Scognamiglio R; Negut C; Ramondo A; Tiengo A; Avogaro A
J Am Coll Cardiol; 2006 Jan; 47(1):65-71. PubMed ID: 16386666
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
[TBL] [Abstract][Full Text] [Related]
5. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
[TBL] [Abstract][Full Text] [Related]
6. [Metabolism of the ischemic myocardium in non-insulin-dependent diabetes].
Uccella R
Minerva Med; 1989 Sep; 80(9):965-8. PubMed ID: 2812481
[TBL] [Abstract][Full Text] [Related]
7. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
8. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
Iannello S; Campione R; Belfiore F
Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
[TBL] [Abstract][Full Text] [Related]
9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
10. [Myocardial metabolism during the pre-ischemic administration of metabolic myocardial protection in coronary surgical patients].
Zwölfer W; Hiesmayr M; Holzinger C; Perger P; Coraim F; Haider W
Anaesthesist; 1990 Oct; 39(10):481-6. PubMed ID: 2278366
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
[TBL] [Abstract][Full Text] [Related]
13. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism in non-diabetic patients with stable coronary artery disease.
Santos JF; Almeida M; Ferreira J; Gonçalves P; Raposo L; Teles R; Branco J; Catroga T; Machado FP; Silva A
Rev Port Cardiol; 2006 Jan; 25(1):39-53. PubMed ID: 16623355
[TBL] [Abstract][Full Text] [Related]
15. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
[TBL] [Abstract][Full Text] [Related]
16. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.
Tuttle KR; Puhlman ME; Cooney SK; Short R
Am J Kidney Dis; 1999 Nov; 34(5):918-25. PubMed ID: 10561150
[TBL] [Abstract][Full Text] [Related]
17. Angiographic severity and morphological spectrum of coronary artery disease in non insulin dependent diabetes mellitus.
Calton R; Calton R; Dhanoa J; Jaison TM
Indian Heart J; 1995; 47(4):343-8. PubMed ID: 8557276
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
Wang G; Wei J; Guan Y; Jin N; Mao J; Wang X
Metabolism; 2005 May; 54(5):590-7. PubMed ID: 15877288
[TBL] [Abstract][Full Text] [Related]
20. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
